<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001001233</cik>
        <entityName>SANGAMO THERAPEUTICS, INC</entityName>
        <fileNumber>000-30171</fileNumber>
        <address>
            <street1>501 Canal Boulevard</street1>
            <street2>Suite A100</street2>
            <city>Richmond</city>
            <stateOrCountryCode>CA</stateOrCountryCode>
            <stateOrCountry>CALIFORNIA</stateOrCountry>
            <zipCode>94804</zipCode>
        </address>
        <telephoneNumber>+1 510 970-6000</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(b)</ruleProvision>

    <signatureData>
        <signatureName>Aravind Menon</signatureName>
        <signatureTitle>Hearings Advisor</signatureTitle>
        <signatureDate>2026-10-06</signatureDate>
    </signatureData>
</notificationOfRemoval>